.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Dow
Accenture
Harvard Business School
Daiichi Sankyo
AstraZeneca
Citi
Mallinckrodt
Deloitte
Teva

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011878

« Back to Dashboard

NDA 011878 describes SERPASIL-ESIDRIX #2, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the SERPASIL-ESIDRIX #2 profile page.

The generic ingredient in SERPASIL-ESIDRIX #2 is hydrochlorothiazide; reserpine. There are thirty-one drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; reserpine profile page.

Summary for 011878

Tradename:2
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG;0.1MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 005

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG;0.1MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
McKesson
US Department of Justice
Argus Health
Cipla
Deloitte
McKinsey
Colorcon
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot